Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Neurochem Int. 2010 Nov 23;59(4):456–464. doi: 10.1016/j.neuint.2010.11.011

Table 1.

Relative specific activities of 13N-metabolites in rat brain after a 10 min-intracarotid artery infusion of [13N]ammonia

Metabolite Controls (n = 4) MSO-treated (n =4) P
Glutamine (amide) [100 ± 29] 8.0 ± 2.3 <0.03
Glutamine (amine) 1.2 ± 0.4 0.6 ± 0.2 NS
Glutamate 0.26 ± 0.07 1.4 ± 0.2 <0.03
Aspartate 0.56 ± 0.14 1.4 ± 0.6 NS

Tracer quantities of [13N]ammonia were administered to immobilized rats for 10 min by continuous infusion via a carotid artery. At the end of the infusion, brains were rapidly frozen, deproteinized and analyzed for 13N-labeled metabolites. Endogenous ammonia levels in the brains of control and MSO-treated rats were 0.181 ± 0.14 (n = 12) and 0.818 ± 0.098 (n – 12) μM, respectively. The specific activities of cerebral GDH in the control and MSO-treated rats were 196 ± 6 and 185 ± 4 μmol/h/g wet weight, respectively; the specific activities of cerebral glutamine synthetase in control and MSO-treated rats were 54.2 ± 2.5 and 7.5 ± 2.6 μmol/h/g wet weight, respectively (n = 12–24). Modified from Cooper et al. (1979). The data reported in this table and tables 2 and 3 are the mean ± SEM.

HHS Vulnerability Disclosure